国立感染症研究所ホームページ

HTLV-1感染症

 HTLV-1感染症  ATLの現状  HAMの現状  HUの現状  参考文献 
HTLV-1の情報ページへ戻る

1) HTLV-1感染症

トップへ戻る

2) ATLの現状

トップへ戻る

3) HAMの現状

トップへ戻る

4) HUの現状

(血液・安全性研究部 山口一成)

トップへ戻る

参考文献

    1. Human T-lymphotropic virus type 1 in Japan.
      Yamaguchi K.
      Lancet 1994 Jan 22:343:213-216
    2. Adult T-cell leukemia: clinical and hematologic features of 16 cases.
      Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H.
      Blood. 1977 Sep;50(3):481-92.
    3. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
      Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC.
      Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9.
    4. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.
      Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I.
      Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80.
    5. HTLV-I associated myelopathy, a new clinical entity.
      Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M.
      Lancet. 1986 May 3;1(8488):1031-2.
    6. Human T lymphotropic virus type 1 uveitis.
      Mochizuki M, Tajima K, Watanabe T, Yamaguchi K.
      Br J Ophthalmol. 1994 Feb;78(2):149-54.
    7. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.
      Seiki M, Hattori S, Hirayama Y, Yoshida M.
      Proc Natl Acad Sci U S A. 1983 Jun;80(12):3618-22.
    8. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).
      Shimoyama M.
      Br J Haematol. 1991 Nov;79(3):428-37.
    9. Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1.
      Yoshida M.
      Leukemia. 1994 Apr;8 Suppl 1:S51-3.
    10. Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission.
      Yamanouchi K, Kinoshita K, Moriuchi R, Katamine S, Amagasaki T, Ikeda S, Ichimaru M, Miyamoto T, Hino S.
      Jpn J Cancer Res. 1985 Jun;76(6):481-7.
    11. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus.
      Tajima K, Tominaga S, Suchi T, Kawagoe T, Komoda H, Hinuma Y, Oda T, Fujita K.
      Gann. 1982 Dec;73(6):893-901.
    12. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.
      Okochi K, Sato H, Hinuma Y.
      Vox Sang. 1984;46(5):245-53.
    13. Primary prevention of HTLV-I in Japan.
      Hino S, Katamine S, Miyata H, Tsuji Y, Yamabe T, Miyamoto T.
      J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S199-203.
    14. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.
      Tajima K.
      Int J Cancer. 1990 Feb 15;45(2):237-43.
    15. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.
      Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K; Joint Study on Predisposing Factors of ATL Development investigators.
      Blood. 2010 Aug 26;116(8):1211-9.
    16. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
      Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M.
      Br J Haematol. 2001 May;113(2):375-82.
    17. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.
      Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, Tara M, Kawano F, Saburi Y, Kikuchi H, Hara M, Sao H, Morishima Y, Kodera Y, Sonoda S, Tomonaga M.
      Bone Marrow Transplant. 2001 Jan;27(1):15-20.
    18. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
      Gill PS, Harrington W Jr, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, et al.
      N Engl J Med. 1995 Jun 29;332(26):1744-8.
    19. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
      Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R.
      J Clin Oncol. 2010 Mar 20;28(9):1591-8.

トップへ戻る

  1. HTLV-1の情報ページへ戻る